SCIENCE. STRATEGY. SOLUTIONS.
PCG 2026 concluded in Mumbai after two days of plenary panels, technical sessions, closed-door leadership roundtables and interactive workshops. Thank you to every regulator, speaker, delegate, partner and supporter who made it possible.
Held Sept 28-29, 2026
Aurika by Lemon Tree Hotels
ATTENDEES
SPEAKERS
PARTNERS
SCIENTIFIC POSTERS
WORKSHOPS
Four ways PCG 2026 brought the community together — from the podium to the show floor.
Plenary panels and technical sessions on manufacturing, analytics, regulation, drug delivery and AI.
View Programme
Closed-door conversations among senior leaders.
Read More
Three technical, interactive workshops.
Read More
Technology providers, CDMOs and partners showcasing solutions across the value chain.
Read More
What's next in the GLP-1 Race?
How to scale peptides from lab to market?
Is India ready to lead in complex therapeutics?
Are oligonucleotides the future?
Can India power the next Billion-Dose era?
The Peptides & Complex Generics Symposium (PCG 2026), organized by Mumbai Biocluster and ICT Mumbai, brought together a curated community of industry leaders, researchers, regulators, CDMOs, startups, and investors to address the evolving landscape of next-generation therapeutics.
Across two days, the programme moved from molecule design and synthesis through analytics, regulation, delivery, devices, manufacturing and market access, with focused discussions across peptides, complex generics, oligonucleotides and advanced therapeutics.
PCG 2026 expanded its lens to Oligonucleotide therapeutics, with a stronger focus on GLP-1, advanced delivery systems, and AI-driven drug development.
It sparked transformative conversations, connected key stakeholders, surfaced opportunities in emerging therapeutics, and offered insights to help translate innovation into real-world solutions.
As the industry shifted from breakthrough science to mass production, the opening plenary asked whether India can scale without compromising quality. Panelists examined how indigenous manufacturing can meet growing demand for complex therapeutics while maintaining stringent GMP compliance, consistent product quality and global regulatory confidence.
Where it all Began
The Peptides & Complex Generics Symposium 2026 has come to a close, and we are grateful to our speakers, delegates, workshop participants and partners for two days of insightful exchange. The conversations that began in Mumbai will continue to shape the future of peptides, complex generics and advanced therapeutics in India and beyond.
September 20th, 2026
ClosedSeptember 28-29, 2026
ConcludedRegistrations for PCG 2026 are now closed. For feedback, partnerships, or information on future editions, reach out to the right point of contact below.